Drug intelligence / Profile preview

ramelteon + gabapentin

Development stage
Unknown
Lead developer
Takeda
Modality
Small Molecules
Administration
Oral
01

Overview

Ramelteon + gabapentin is a combination of two pharmaceutical drugs, each with distinct mechanisms of action. Ramelteon is a selective melatonin receptor agonist that acts primarily at the MT1 and MT2 receptors in the brain's suprachiasmatic nucleus, promoting sleep by regulating circadian rhythms[4][6]. Gabapentin is an anticonvulsant and neuropathic pain agent that modulates voltage-gated calcium channels to reduce excitatory neurotransmitter release. When used together, these agents may have additive central nervous system depressant effects, increasing risks such as sedation, dizziness, drowsiness, confusion, and impaired psychomotor skills[1][2][3]. This combination does not represent a fixed-dose product but rather concurrent use of two approved medications for their respective indications.

02

Targets

MTNR1A (MT1)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)MTNR1B (Melatonin Receptor 2)

Beyond the preview

Go deeper on ramelteon + gabapentin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ramelteon + gabapentin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call